Navigation Links
PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
Date:12/7/2012

Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect PROLOR's business and prospects, including the risks that PROLOR may not succeed in generating any revenues or developing any commercial products, including any long-acting versions of human growth hormone, erythropoietin, interferon beta, GLP-1 and other products; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from Israel's Office of the Chief Scientist is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties.  In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchang
'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GenWay Biotech Appoints New Vice President of Custom/OEM
2. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
3. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
4. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
7. Obamacare Ruling, Other Pivotal News Rocks Biotech Sector in June
8. Tougher Times May be Ahead for Biotechs: 1H12 Fundraising Slows
9. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Lifeline Biotechnologies First Warning Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
(Date:3/3/2015)... , March 3, 2015  AT&T 1 ... today announced that  AT&T  is the connectivity provider for ... was designed to help provide peace of mind to ... the freedom to live active lives with the confidence ... need it. The AT&T network 2 helps power ...
(Date:3/3/2015)... 3, 2015  Cyberonics, Inc. (NASDAQ: CYBX ... treatment and management of epilepsy, today announced it will ... March 11, 2015, in Miami . ... Chief Executive Officer, will speak at 1:05 PM Eastern ... chat format, and no formal materials will be presented.  ...
Breaking Medicine Technology:Web Industries Receives 3M Preferred Converter Status 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4
... Data presented at AACR 2008, SAN DIEGO, ... owned subsidiary of Cell Therapeutics, Inc. (CTI) (Nasdaq,and ... demonstrating that,the Company,s experimental drug candidate, brostallicin, killed ... status. The study, conducted,by Cristina Geroni, Ph.D., et ...
... Inc.,(Nasdaq: MITI ), a biopharmaceutical company developing ... autoimmune diseases, today,presented at the Annual Meeting of ... Diego, CA, preclinical data of two new human ... of acute myelogenous,leukaemia (AML) and melanoma (1). BiTE ...
Cached Medicine Technology:Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling 2Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability Based on Genetic Profiling 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 2Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 3Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 4Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma 5
(Date:3/3/2015)... Loma Linda University Health announced today, ... being, it will be offering new, healthier choices in ... Over the past year, a cross-section of Loma Linda ... criteria, listening to vendors, sampling their products, and ultimately ... , Most recently, a food fair was held during ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Today, Steve ... former Seattle Seahawks wide receiver, announced the donation of ... timing with Brain Injury Awareness Month. In an effort ... and the importance of brain health, Rice and Weatherford ... and the need to make brain health a priority ...
(Date:3/3/2015)... Man, Woman & Student of the Year engages ... ensure access to treatments for blood cancer patients, and ... families. Through this annual national ten-week campaign, individuals can ... world without blood cancers. The national titles will be ... be announced this summer. To date, these dedicated leaders ...
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles ... crimes, recently spoke on the radio to give his insights ... the Independent Journal Review radio show “The Right Mics” chose ... prosecutor and now as a criminal defense attorney would provide ... trial and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... March 03, 2015 Today the Brain ... maker of bike, skate, snow, water, and motorcycle helmets, ... brain injury. The partnership kicks off with Nutcase donating ... http://www.nutcasehelmets.com to BIAA during the month of ... Each year BIAA leads the nation in observing Brain ...
Breaking Medicine News(10 mins):Health News:Loma Linda University Health Rejuvenates Its Vending Machines with Healthier Selections 2Health News:Steve Weatherford and Sidney Rice Reveal Donation for Brain Injury Awareness Month 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 2Health News:The Leukemia & Lymphoma Society’s Oregon and SW Washington Chapter Kicks Off Their Eleventh Annual Man, Woman & Student of the Year Campaign 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2
... Billion increased 4.3%; Full-Year EPS was $4.572008 Fourth-Quarter Sales ... Items, 2008 Full-Year EPS was $4.55, an increase of ... 6.8%* , NEW BRUNSWICK, N.J., Jan. 20 Johnson ... of $63.7 billion, an increase of 4.3% over 2007. ...
... Successful and Productive Call Centers are Created with Used Cubicles. ... ... www.thefsi.com --The Furniture Source, provider of new and ... call centers enhance the success of their business by helping to ...
... in popularity and industry technology continues to advance, The Swan Center ... For breast augmentation, Atlanta GA women look to The ... , ... Atlanta, GA (PRWEB) January 20, 2009 -- In ...
... consultative approach to work with clients in these tough economic times. ... ... times the staffing industry is being hit hard. To succeed, CMS, ... them look at strategic hiring moves such as utilizing the temporary workforce. ...
... SINGAPORE, Jan. 20 Abbott ( ... new pharmaceutical analytical research laboratory,in Singapore,s Biopolis research ... development site in Southeast Asia, will conduct,stability studies, ... to support global regulatory requirements for new,pharmaceutical products. ...
... the first-ever study of food adverts in UK magazines, ... contradicting the health messages the articles were trying to ... on a healthier lifestyle, yet we found the food ... and low in fibre such as ready meals, sauces ...
Cached Medicine News:Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 2Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 3Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 4Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 5Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 6Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 7Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 8Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 9Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 10Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 11Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 12Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 13Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 14Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 15Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 16Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 17Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 18Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 19Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 20Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 21Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 22Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 23Health News:Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results 24Health News:Used Cubicles from The Furniture Source Help to Eliminate Cubicle Claustrophobia in Call Centers 2Health News:For Breast Augmentation, Atlanta's Swan Center for Plastic Surgery Offers Exceptional Surgeons' Skills 2Health News:For Breast Augmentation, Atlanta's Swan Center for Plastic Surgery Offers Exceptional Surgeons' Skills 3Health News:For Breast Augmentation, Atlanta's Swan Center for Plastic Surgery Offers Exceptional Surgeons' Skills 4Health News:CMS Staffing Announces a its New and Revolutionary Consultative Approach With Clients 2Health News:Abbott Opens New Pharmaceutical Research Laboratory in Singapore 2Health News:Abbott Opens New Pharmaceutical Research Laboratory in Singapore 3Health News:Food advertisements in your magazine: How healthy are they? 2
... Latex Foley Catheter, Smooth, non-stick silicone ... but flexible, latex-based construction with large ... round tip with two opposing eyes ... two staggered eyes and a 30cc ...
... 3-way design permits continuous irrigation ... in the Foley Catheter. 3-Way ... construction, as well as LUBRICATH ... variety of models including Suggs, ...
Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: